EUVIMEDEUVIMED entdecken
Crossref

TLR7-Induced Mitochondrial Reactive Oxygen Species Production in Monocyte-derived Dendritic Cells Drives IL-12–Dependent NK Cell Activation and Enhances Antitumor Immunity

Ankush Paladhi iD, Samrat Daripa iD, Arghya Nath, Sumit Kumar Hira iD

The Journal of Immunology · 2024

DOI: 10.4049/jimmunol.2400340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Ankush Paladhi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Immunology Laboratory, Department of Zoology, University of Burdwan, Bardhaman, India. Hauptthemen laut MEDLINE: Dendritic Cells, Toll-Like Receptor 7, Reactive Oxygen Species, Interleukin-12. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: DST | Science and Engineering Research Board (SERB), Council of Scientific and Industrial Research, India (CSIR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dendritic cell (DC)–based vaccines are promising immunotherapies for cancer. Although DC-based therapies are known to activate tumor-specific T cells, the interplay between DCs and NK cells in this setting is not fully understood. In this study, we demonstrated a novel TLR7/ mitochondrial reactive oxygen species (mROS)/IL-12 axis that drives potent NK cell responses against tumors. We showed that TLR7 activation by imiquimod in peripheral blood monocyte-derived CD11c+ DCs triggered mROS production, leading to enhanced IL-12 secretion and subsequent NK cell activation, as evidenced by increased IFN-γ production and tumor cell cytotoxicity. Notably, mROS neutralization abrogates NK cell–mediated tumor cell lysis, and TLR7-mediated DC activation of NK cells occurs independently of MyD88, suggesting involvement of the noncanonical NF-κB pathway. Our findings provide a rationale for targeting the TLR7/mROS/IL-12 axis to enhance the efficacy of DC-based cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsToll-Like Receptor 7Reactive Oxygen SpeciesInterleukin-12Killer Cells, NaturalMitochondriaLymphocyte ActivationHumansImiquimodMonocytesMyeloid Differentiation Factor 88NeoplasmsCell Line, TumorAminoquinolinesAnimals

Substanzen

Toll-Like Receptor 7Reactive Oxygen SpeciesInterleukin-12TLR7 protein, humanImiquimodMyeloid Differentiation Factor 88Aminoquinolines

Autor:innen und Institutionen

  • Cellular Immunology Laboratory, Department of Zoology, University of Burdwan, Bardhaman, India.
  • ICMR-DHR-VRDL, Burdwan Medical College and Hospital, Bardhaman, India.

ORCID-Profile: Ankush Paladhi, Samrat Daripa, Sumit Kumar Hira

Förderung

  • DST | Science and Engineering Research Board (SERB)
  • Council of Scientific and Industrial Research, India (CSIR)

Zitieren

APA

Paladhi, A., Daripa, S., Nath, A., & Hira, S. K. (2024). TLR7-Induced Mitochondrial Reactive Oxygen Species Production in Monocyte-derived Dendritic Cells Drives IL-12–Dependent NK Cell Activation and Enhances Antitumor Immunity. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2400340

Vancouver

Paladhi A, Daripa S, Nath A, Hira SK. TLR7-Induced Mitochondrial Reactive Oxygen Species Production in Monocyte-derived Dendritic Cells Drives IL-12–Dependent NK Cell Activation and Enhances Antitumor Immunity. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2400340

BibTeX
@article{Paladhi2024,
  author = {Paladhi, Ankush and Daripa, Samrat and Nath, Arghya and Hira, Sumit Kumar},
  title = {TLR7-Induced Mitochondrial Reactive Oxygen Species Production in Monocyte-derived Dendritic Cells Drives IL-12–Dependent NK Cell Activation and Enhances Antitumor Immunity},
  journal = {The Journal of Immunology},
  year = {2024},
  doi = {10.4049/jimmunol.2400340}
}
Kostenlos starten →